Hotchkis & Wiley Capital Management Adds $97M in Humana Inc. ($HUM)

Key Points

  • Hotchkis & Wiley Capital Management changed its Humana Inc. ($HUM) stake by 18% last quarter, boosting to 1,609,024 shares worth $638.91 million.
  • Wall Street's consensus rating on $HUM is Buy and an average price target of $418.61.
  • $HUM last traded around $397.08.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Hotchkis & Wiley Capital Management increased its position in Humana Inc. ($HUM) by 18% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,609,024 shares of Humana Inc. after buying 245,496 shares during the quarter. Hotchkis & Wiley Capital Management's holdings in Humana Inc. were worth $638.91 million as of its most recent filing.

Humana Inc. Stock Up 3.0%

Shares of Humana Inc. ($HUM) traded around $397.08 on Saturday, up 3.0% for the day.

Last price$397.08
Market cap$46.02B
P/E ratio36.50
Forward P/E23.13
PEG ratio2.22
Beta0.74
52-week low$163.11
52-week high$428.88
50-day MA$384.97
200-day MA$275.75
Current ratio1.74
Quick ratio1.28
Debt-to-equity0.76

Humana Inc. Earnings

EPS (ttm)$10.50
Revenue (ttm)$145.68B
Revenue growth26.20%
Net margin0.88%
Return on equity6.89%
Next earningsNov 6, 2026

Humana Inc. Dividend

Annual dividend$3.54
Dividend yield92%
Payout ratio33.46%
Ex-dividend dateJun 26, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$418.61
High target$513
Low target$280
Analysts covering23

About Humana Inc.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

ExchangeNYSE
SectorHealthcare
IndustryHealthcare Plans
HeadquartersLouisville, KY
CEOMr. James A. Rechtin M.B.A.
Employees67,060

Get Humana Inc. alerts

New 13F filings, insider trades, and analyst moves on $HUM, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.